Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in Gastroenterology

Retrieve available abstracts of 86 articles:
HTML format
Text format



Single Articles


    September 2017
  1. CHILDS-KEAN LM, Hong J
    Detectable Viremia at the End of Treatment With Direct-Acting Antivirals Can Be Associated With Subsequent Clinical Cure in Patients With Chronic Hepatitis C: A Case Series.
    Gastroenterology. 2017 Sep 4. pii: S0016-5085(17)35912.
    PubMed     Text format    


    August 2017
  2. MAAN R, Feld JJ
    Risk for hepatocellular carcinoma after HCV antiviral therapy with direct-acting antivirals: case closed?
    Gastroenterology. 2017 Aug 31. pii: S0016-5085(17)36085.
    PubMed     Text format    


  3. YU ML
    Resistance-Associated Substitutions in Short Duration of Interferon-Free Direct-Acting Antivirals for Hepatitis C.
    Gastroenterology. 2017 Aug 3. pii: S0016-5085(17)35886.
    PubMed     Text format    


  4. BOLTE FJ, O'Keefe AC, Webb LM, Serti E, et al
    Intra-hepatic Depletion of Mucosal Associated Invariant T cells in Hepatitis C Virus-induced Liver Inflammation.
    Gastroenterology. 2017 Aug 2. pii: S0016-5085(17)35975.
    PubMed     Text format     Abstract available


    July 2017
  5. MISHRA P, Florian J, Peter J, Vainorius M, et al
    Public-Private Partnership: Targeting Real-World Data for Hepatitis C Direct-Acting Antivirals.
    Gastroenterology. 2017 Jul 27. pii: S0016-5085(17)35956.
    PubMed     Text format    


  6. LENS S, Alvarado E, Marino Z, Londono MC, et al
    Effects of All-oral Anti-viral Therapy on HVPG and Systemic Hemodynamics in Patients with Hepatitis C Virus-associated Cirrhosis.
    Gastroenterology. 2017 Jul 19. pii: S0016-5085(17)35922.
    PubMed     Text format     Abstract available


  7. YU MW, Lin CL, Liu CJ, Yang SH, et al
    Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-related Death in Men with Chronic Hepatitis B: A Large Cohort Study.
    Gastroenterology. 2017 Jul 12. pii: S0016-5085(17)35866.
    PubMed     Text format     Abstract available


    June 2017
  8. KANWAL F, Kramer J, Asch SM, Chayanupatkul M, et al
    Risk of Hepatocellular Cancer in HCV Patients Treated with Direct Acting Antiviral Agents.
    Gastroenterology. 2017 Jun 19. pii: S0016-5085(17)35797.
    PubMed     Text format     Abstract available


  9. ENOMOTO M, Murakami Y, Kawada N
    Detection of HCV RNA in Sustained Virologic Response to Direct-Acting Antiviral Agents: Occult or Science Fiction?
    Gastroenterology. 2017 Jun 2. pii: S0016-5085(17)35638.
    PubMed     Text format    


  10. DE MARCO L, Pellicano R
    When to Search for Occult Infection After Eradication of Hepatitis C?
    Gastroenterology. 2017 Jun 2. pii: S0016-5085(17)35601.
    PubMed     Text format    


    May 2017
  11. KANWAL F, Bacon BR, Beste LA, Brill JV, et al
    Hepatitis C Virus Infection Care Pathway-A Report From the American Gastroenterological Association Institute HCV Care Pathway Work Group.
    Gastroenterology. 2017;152:1588-1598.
    PubMed     Text format    


  12. SINGH S, Muir AJ, Dieterich DT, Falck-Ytter YT, et al
    American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.
    Gastroenterology. 2017;152:1544-1577.
    PubMed     Text format     Abstract available


    April 2017
  13. LAIDLAW SM, Marukian S, Gilmore RH, Cashman SB, et al
    Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent from Interferons.
    Gastroenterology. 2017 Apr 26. pii: S0016-5085(17)35530.
    PubMed     Text format     Abstract available


  14. JACOBSON IM, Lawitz E, Gane EJ, Willems BE, et al
    Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir In Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials.
    Gastroenterology. 2017 Apr 5. pii: S0016-5085(17)35399.
    PubMed     Text format     Abstract available


    March 2017
  15. JACOBSON IM, Lim JK, Fried MW
    AGA Institute Clinical Practice Update: Care of Patients Who Have Achieved a Sustained Virologic Response (SVR) Following Antiviral Therapy for Chronic Hepatitis C Infection.
    Gastroenterology. 2017 Mar 23. pii: S0016-5085(17)30327.
    PubMed     Text format     Abstract available


  16. MISHRA P, Chen M
    Direct-Acting Antivirals for Chronic Hepatitis C: Can Drug Properties Signal Potential for Liver Injury?
    Gastroenterology. 2017 Mar 18. pii: S0016-5085(17)30295.
    PubMed     Text format    


  17. SAADOUN D, Pol S, Ferfar Y, Alric L, et al
    Efficacy and Safety of Sofosbuvir plus Daclatasvir for Treatment of HCV-associated Cryoglobulinemia Vasculitis.
    Gastroenterology. 2017 Mar 10. pii: S0016-5085(17)30269.
    PubMed     Text format     Abstract available


  18. COMARMOND C, Garrido M, Pol S, Desbois AC, et al
    Direct-acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-induced Cryoglobulinemia Vasculitis.
    Gastroenterology. 2017 Mar 5. pii: S0016-5085(17)30235.
    PubMed     Text format     Abstract available


  19. LIAW YF, Chu CM
    Immune Tolerance Phase of Chronic Hepatitis B.
    Gastroenterology. 2017 Mar 5. pii: S0016-5085(17)30137.
    PubMed     Text format    


  20. SINGAL AK, Shah VH, Kamath PS
    Infection in Severe Alcoholic Hepatitis: Yet Another Piece in the Puzzle.
    Gastroenterology. 2017 Mar 1. pii: S0016-5085(17)30217.
    PubMed     Text format    


    February 2017
  21. KLIGMAN E, Kwo PY
    Confirming What We Believed: Reducing and Eliminating Vertical Transmission of Hepatitis B.
    Gastroenterology. 2017 Feb 28. pii: S0016-5085(17)30206.
    PubMed     Text format    


  22. AGHEMO A, Colombo M
    Response-Guided Duration of Directly Acting Antiviral Therapy for Chronic Hepatitis C: Back to the Future?
    Gastroenterology. 2017 Feb 27. pii: S0016-5085(17)30205.
    PubMed     Text format    


  23. LOOMBA R, Liang TJ
    Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies and future directions.
    Gastroenterology. 2017 Feb 17. pii: S0016-5085(17)30173.
    PubMed     Text format     Abstract available


  24. JACOBSON IM, Lawitz E, Kwo PY, Hezode C, et al
    Safety and Efficacy of Elbasvir/Grazoprevir in Patients with Hepatitis C Virus Infection and Compensated Cirrhosis: an Integrated Analysis.
    Gastroenterology. 2017 Feb 10. pii: S0016-5085(17)30150.
    PubMed     Text format     Abstract available


  25. MATSUURA K, Sawai H, Ikeo K, Ogawa S, et al
    Genome-wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Gastroenterology. 2017 Feb 2. pii: S0016-5085(17)30130.
    PubMed     Text format     Abstract available


  26. RAVI S, Axley P, Jones D, Kodali S, et al
    Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis.
    Gastroenterology. 2017 Feb 1. pii: S0016-5085(16)35535.
    PubMed     Text format    


    January 2017
  27. GANE EJ, Hyland RH, Yang Y, Svarovskaia E, et al
    Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection.
    Gastroenterology. 2017 Jan 27. pii: S0016-5085(17)30074.
    PubMed     Text format     Abstract available


  28. GOLDBERG D, Ditah IC, Saeian K, Lalehzari M, et al
    Changes in the Prevalence of Hepatitis C Virus Infection, Non-alcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients with Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
    Gastroenterology. 2017 Jan 11. pii: S0016-5085(17)30014.
    PubMed     Text format     Abstract available


  29. BESSE-PATIN A, Leveille M, Oropeza D, Nguyen BN, et al
    Estrogen Signals Through Peroxisome Proliferator-Activated Receptor-gamma Coactivator 1alpha to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease.
    Gastroenterology. 2017;152:243-256.
    PubMed     Text format     Abstract available


    December 2016
  30. VERGIS N, Atkinson SR, Knapp S, Maurice J, et al
    Patients With Severe Alcoholic Hepatitis Given Prednisolone Therapy Who Have High Circulating Levels Of Bacterial DNA are at Increased Risk for Developing Infections.
    Gastroenterology. 2016 Dec 30. pii: S0016-5085(16)35533.
    PubMed     Text format     Abstract available


  31. KOUTSOUDAKIS G, Perez-Del-Pulgar S, Forns X
    Occult Hepatitis C Virus Infection: Are We Digging Too Deep?
    Gastroenterology. 2016 Dec 27. pii: S0016-5085(16)35528.
    PubMed     Text format    


  32. BOSON B, Denolly S, Turlure F, Chamot C, et al
    Daclatasvir Prevents Hepatitis C Virus by Blocking Transfer of Viral Genome to Assembly Sites.
    Gastroenterology. 2016 Dec 5. pii: S0016-5085(16)35447.
    PubMed     Text format     Abstract available


    November 2016
  33. COLPITTS CC, Baumert TF
    SMAD about HCV cell entry and pathogenesis of liver disease.
    Gastroenterology. 2016 Nov 23. pii: S0016-5085(16)35398.
    PubMed     Text format    


  34. DONNELLY MC, Imlach SN, Abravanel F, Ramalingam S, et al
    Sofosbuvir and Daclatasvir Anti-Viral Therapy Fails to Clear HEV Viremia and Restore Reactive T Cells in a HEV/HCV Co-Infected Liver Transplant Recipient.
    Gastroenterology. 2016 Nov 21. pii: S0016-5085(16)34895.
    PubMed     Text format    


  35. ELMASRY S, Wadhwa S, Bang BR, Cook L, et al
    Detection of Occult Hepatitis C Virus Infection in Patients Who Achieved a Sustained Virologic Response to Direct-acting Antiviral Agents for Recurrent Infection After Liver Transplantation.
    Gastroenterology. 2016 Nov 9. pii: S0016-5085(16)35323.
    PubMed     Text format     Abstract available


  36. WANG W, Hakim MS, Nair VP, de Ruiter PE, et al
    Distinct Antiviral Potency of Sofosbuvir against Hepatitis C and E Viruses.
    Gastroenterology. 2016 Nov 1. pii: S0016-5085(16)35194.
    PubMed     Text format    


    October 2016
  37. KOMATSU TE, Boyd S, Sherwat A, Tracy L, et al
    Regulatory Analysis of Effects of Hepatitis C Virus NS5A Polymorphisms on Efficacy of Elbasvir and Grazoprevir.
    Gastroenterology. 2016 Oct 20. pii: S0016-5085(16)35241.
    PubMed     Text format     Abstract available


  38. LIANG TJ
    Hepatitis C Virus: from Obscurity to the Lasker.
    Gastroenterology. 2016 Oct 17. pii: S0016-5085(16)35233.
    PubMed     Text format    


  39. KWO P, Gane E, Peng CY, Pearlman B, et al
    Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients with Chronic Hepatitis C Infection.
    Gastroenterology. 2016 Oct 5. pii: S0016-5085(16)35170.
    PubMed     Text format     Abstract available


  40. AGHEMO A, Buti M
    Hepatitis C Therapy: Game Over!
    Gastroenterology. 2016 Oct 1. pii: S0016-5085(16)35131.
    PubMed     Text format    


  41. PROTZER U, Knolle P
    "To Be or Not to Be": Immune Tolerance in Chronic Hepatitis B.
    Gastroenterology. 2016 Oct 1. pii: S0016-5085(16)35135.
    PubMed     Text format    


  42. MILICH DR
    The Concept of Immune Tolerance in Chronic Hepatitis B Virus Infection Is Alive and Well.
    Gastroenterology. 2016 Oct 1. pii: S0016-5085(16)35134.
    PubMed     Text format    


    September 2016
  43. ZHANG F, Sodroski C, Cha H, Li Q, et al
    Infection of Hepatocytes with HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Upregulating SMAD6 and SMAD7.
    Gastroenterology. 2016 Sep 29. pii: S0016-5085(16)35128.
    PubMed     Text format     Abstract available


  44. NAHON P, Bourcier V, Layese R, Audureau E, et al
    Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.
    Gastroenterology. 2016 Sep 15. pii: S0016-5085(16)35070.
    PubMed     Text format     Abstract available


    August 2016
  45. PAWLOTSKY JM
    Hepatitis C Drugs: Is Next Generation the Last Generation?
    Gastroenterology. 2016 Aug 30. pii: S0016-5085(16)34985.
    PubMed     Text format    


  46. TERRAULT NA, Zeuzem S, Di Bisceglie AM, Lim JK, et al
    Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated of Sustained Virologic Response.
    Gastroenterology. 2016 Aug 23. pii: S0016-5085(16)34927.
    PubMed     Text format     Abstract available


  47. SETH A, Alexander JS, Jordan PA
    A Rare Cause of Hepatitis: "Think Outta the Box!"
    Gastroenterology. 2016 Aug 1. pii: S0016-5085(16)34435.
    PubMed     Text format    


    July 2016
  48. LAWITZ E, Reau N, Hinestrosa F, Rabinovitz M, et al
    Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients with Genotype 1 Hepatitis C Virus Infection in an Open-label, Phase 2 Trial.
    Gastroenterology. 2016 Jul 30. pii: S0016-5085(16)34835.
    PubMed     Text format     Abstract available


  49. GANE E, Kowdley KV, Pound D, Stedman CA, et al
    Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients with HCV Genotype 2, 3, 4, or 6 Infections in an Open-label, Phase 2 Trial.
    Gastroenterology. 2016 Jul 30. pii: S0016-5085(16)34834.
    PubMed     Text format     Abstract available


  50. AFDHAL NH, Serfaty L
    Cohort Studies and Registries in the treatment of HCV; the impact of "real life" effectiveness.
    Gastroenterology. 2016 Jul 22. pii: S0016-5085(16)34820.
    PubMed     Text format    


  51. SHERMAN M
    Hepatitis B vaccination: Putting hepatologists out of business?
    Gastroenterology. 2016 Jul 22. pii: S0016-5085(16)34819.
    PubMed     Text format    


  52. GANE E, Poordad F, Wang S, Asatryan A, et al
    High Efficacy of ABT-493 and ABT-530 in Patients with HCV Genotype 1 or 3 Infection and Compensated Cirrhosis.
    Gastroenterology. 2016 Jul 22. pii: S0016-5085(16)34816.
    PubMed     Text format     Abstract available


  53. MASON WS, Gill US, Litwin S, Zhou Y, et al
    HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant.
    Gastroenterology. 2016 Jul 21. pii: S0016-5085(16)34808.
    PubMed     Text format     Abstract available


  54. RAMIREZ S, Mikkelsen LS, Gottwein JM, Bukh J, et al
    Robust HCV Genotype 3a Infectious Cell Culture System Permits Identification of Escape Variants With Resistance to Sofosbuvir.
    Gastroenterology. 2016 Jul 21. pii: S0016-5085(16)34809.
    PubMed     Text format     Abstract available


  55. SHIN JY, Azoulay L, Filion KB
    Statin Use in Patients With Hepatitis C-related Cirrhosis: True Benefit or Immortal Time Bias?
    Gastroenterology. 2016 Jul 1. pii: S0016-5085(16)34434.
    PubMed     Text format    


    June 2016
  56. GAMBATO M, Perez-Del-Pulgar S, Hedskog C, Svarovskia ES, et al
    HCV RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free Regimen.
    Gastroenterology. 2016 Jun 30. pii: S0016-5085(16)34697.
    PubMed     Text format     Abstract available


  57. SARRAZIN C, Dvory-Sobol H, Svarovskaia ES, Doehle B, et al
    Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment with Ledipasvir and Sofosbuvir.
    Gastroenterology. 2016 Jun 10. pii: S0016-5085(16)34614.
    PubMed     Text format     Abstract available


  58. IOANNOU GN, Beste LA, Chang MF, Green PK, et al
    Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Healthcare System.
    Gastroenterology. 2016 Jun 4. pii: S0016-5085(16)34575.
    PubMed     Text format     Abstract available


  59. CHANG MH, You SL, Chen CJ, Liu CJ, et al
    Long-Term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer.
    Gastroenterology. 2016 Jun 3. pii: S0016-5085(16)34574.
    PubMed     Text format     Abstract available


    May 2016
  60. GANE EJ, Schwabe C, Hyland RH, Yang Y, et al
    Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-naive or Previously Treated Patients with HCV Genotype 1 or 3 Infections.
    Gastroenterology. 2016 May 27. pii: S0016-5085(16)34513.
    PubMed     Text format     Abstract available


  61. KLINGE MJ, Borhani AA, Malik SM
    Hepatitis C and Numerous Disappearing Hepatic Nodules: No-dule C It, No-dule Don't.
    Gastroenterology. 2016 May 27. pii: S0016-5085(16)30099.
    PubMed     Text format    


    April 2016
  62. WANG W, Peppelenbosch MP, Pan Q
    Targeting Viral Polymerase for Treating Hepatitis E Infection: How Far Are We?
    Gastroenterology. 2016 Apr 29. pii: S0016-5085(16)00362.
    PubMed     Text format    


  63. PAWLOTSKY JM
    Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens.
    Gastroenterology. 2016 Apr 11. pii: S0016-5085(16)30055.
    PubMed     Text format     Abstract available


    March 2016
  64. DI MARCO V, Calvaruso V, Ferraro D, Bavetta MG, et al
    Effects of Viral Eradication in Patients with HCV and Cirrhosis Differ With Stage of Portal Hypertension.
    Gastroenterology. 2016 Mar 31. pii: S0016-5085(16)30049.
    PubMed     Text format     Abstract available


  65. SONNEVELD MJ, Brouwer WP, van der Meer AJ
    Posttreatment Hepatitis B Surface Antigen Seroreversion: The Bane of Combination Therapy in Chronic Hepatitis B?
    Gastroenterology. 2016 Mar 25. pii: S0016-5085(16)00328.
    PubMed     Text format    


  66. AGHEMO A, Colombo M
    No Time for Bullies in Hepatitis C Virus Therapy: Genotype 3 Conquered?
    Gastroenterology. 2016 Mar 24. pii: S0016-5085(16)00378.
    PubMed     Text format    


  67. POCKROS PJ, Reddy KR, Mantry PS, Cohen E, et al
    Efficacy of Direct-acting Antiviral Combination for Patients with HCV Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease.
    Gastroenterology. 2016 Mar 11. pii: S0016-5085(16)00326.
    PubMed     Text format     Abstract available


  68. THURSZ M, Morgan TR
    Treatment of Severe Alcoholic Hepatitis.
    Gastroenterology. 2016 Mar 3. pii: S0016-5085(16)00295.
    PubMed     Text format     Abstract available


    February 2016
  69. SCHATTENBERG JM, Lee MS
    Extracellular Vesicles as Messengers between Hepatocytes and Macrophages in Nonalcoholic Steatohepatitis.
    Gastroenterology. 2016 Feb 27. pii: S0016-5085(16)00255.
    PubMed     Text format    


  70. PURI P, Thursz M
    Intensive Enteral Nutrition in Alcoholic Hepatitis: More Food for Thought.
    Gastroenterology. 2016 Feb 26. pii: S0016-5085(16)00252.
    PubMed     Text format    


  71. YOUNOSSI Z, Park H, Henry L, Adeyemi A, et al
    Extra-Hepatic Manifestations of Hepatitis C-a Meta-Analysis of Prevalence, Quality of Life, and Economic Burden.
    Gastroenterology. 2016 Feb 25. pii: S0016-5085(16)00230.
    PubMed     Text format     Abstract available


  72. CRABB DW, Bataller R, Chalasani NP, Kamath PS, et al
    Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia.
    Gastroenterology. 2016 Feb 24. pii: S0016-5085(16)00233.
    PubMed     Text format    


  73. SERFATY L
    Clinical implications of concomitant alcohol use, obesity and viral hepatitis.
    Gastroenterology. 2016 Feb 9. pii: S0016-5085(16)00139.
    PubMed     Text format    


  74. HASSAN T, Khan F, Kyprianou A
    A Not So Benign Abdomen!
    Gastroenterology. 2016;150:e1-2.
    PubMed     Text format    


    January 2016
  75. MORENO C, Deltenre P, Senterre C, Louvet A, et al
    Intensive Enteral Nutrition is Ineffective for Individuals with Severe Alcoholic Hepatitis Treated with Corticosteroids.
    Gastroenterology. 2016 Jan 4. pii: S0016-5085(15)01866.
    PubMed     Text format     Abstract available


  76. HIRSOVA P, Ibrahim SH, Krishnan A, Verma VK, et al
    Lipid-induced Signaling Causes Release of Inflammatory Extracellular Vesicles from Hepatocytes.
    Gastroenterology. 2016 Jan 4. pii: S0016-5085(15)01865.
    PubMed     Text format     Abstract available


  77. XUE R, Li R, Guo H, Guo L, et al
    Variable Extent of Intra-tumor Heterogeneity Revealed by Genomic Sequencing of Multiple Lesions in Patients with Hepatocellular Carcinoma.
    Gastroenterology. 2016 Jan 2. pii: S0016-5085(15)01861.
    PubMed     Text format     Abstract available


  78. XIA Y, Stadler D, Lucifora J, Reisinger F, et al
    Interferon-gamma and Tumor Necrosis Factor-alpha Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.
    Gastroenterology. 2016;150:194-205.
    PubMed     Text format     Abstract available


    December 2015
  79. PARK JJ, Wong DK, Wahed AS, Lee WM, et al
    HBV-specific and global T-cell dysfunction in chronic hepatitis B.
    Gastroenterology. 2015 Dec 9. pii: S0016-5085(15)01736.
    PubMed     Text format     Abstract available


    November 2015
  80. MCMAHON BJ
    Combination of Pegylated Interferon and Tenofovir for Hepatitis B Treatment: Screening and Counseling of Patients are Warranted.
    Gastroenterology. 2015 Nov 22. pii: S0016-5085(15)01675.
    PubMed     Text format    


  81. BLOCK T, Guo JT
    The Covalently Closed Circular Form of Hepatitis B Virus Genome: Is There Now an End in Site?
    Gastroenterology. 2015 Nov 22. pii: S0016-5085(15)01679.
    PubMed     Text format    


  82. RAZIORROUH B, Sacher K, Tawar RG, Emmerich F, et al
    Virus-specific CD4+ T Cells Have Functional and Phenotypic Characteristics of Follicular T-helper Cells in Patients With Acute and Chronic HCV Infections.
    Gastroenterology. 2015 Nov 13. pii: S0016-5085(15)01622.
    PubMed     Text format     Abstract available


    October 2015
  83. LAMMERT C, Comerford M, Love J, Bailey JR, et al
    Investigation Gone Viral: Application of the Social Mediasphere in Research.
    Gastroenterology. 2015;149:839-43.
    PubMed     Text format    


    September 2015
  84. KLEMANN C, Schroder A, Dreier A, Mohn N, et al
    Interleukin-17, Produced by gammadelta-T Cells, Contributes to Hepatic Inflammation in a Mouse Model of Biliary Atresia and is Increased in Livers of Patients.
    Gastroenterology. 2015 Sep 21. pii: S0016-5085(15)01352.
    PubMed     Text format     Abstract available


    August 2015
  85. BESTE LA, Leipertz SL, Green PK, Dominitz JA, et al
    Trends in the burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US Veterans from 2001-2013.
    Gastroenterology. 2015 Aug 5. pii: S0016-5085(15)01088.
    PubMed     Text format     Abstract available


    June 2015
  86. ZUCMAN-ROSSI J, Villanueva A, Nault JC, Llovet JM, et al
    The genetic landscape and biomarkers of hepatocellular carcinoma.
    Gastroenterology. 2015 Jun 19. pii: S0016-5085(15)00869.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: